- Home
- AMRN vs ZTR Comparison
AMRN vs ZTR Comparison
Compare AMRN & ZTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$14.74
Company Overview
Basic Information| Metric | AMRN | ZTR |
|---|---|---|
| Founded | 1989 | N/A |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 339.8M | 357.2M |
| IPO Year | 1998 | 1995 |
Fundamental Metrics
Financial Performance| Metric | AMRN | ZTR |
|---|---|---|
| Price | $14.74 | $6.76 |
| Analyst Decision | Strong Sell | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | 54.5K | ★ 189.1K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 55.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $181,104,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.26 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 39.22 | N/A |
| 52 Week Low | $0.39 | $5.22 |
| 52 Week High | $20.90 | $7.11 |
Technical Indicators
Market Signals| Indicator | AMRN | ZTR |
|---|---|---|
| Relative Strength Index (RSI) | 49.09 | 52.91 |
| Support Level | $14.39 | $6.71 |
| Resistance Level | $16.95 | $6.92 |
| Average True Range (ATR) | 0.56 | 0.09 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 47.52 | 66.96 |
Price Performance
Historical Comparison AMRN
ZTR
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
About ZTR Virtus Total Return Fund Inc.
Virtus Total Return Fund Inc is a closed-end, diversified management investment company. Its investment objective of capital appreciation, with current income as a secondary objective. The Fund seeks to meet its objectives through a balance of equity and fixed income investments.